Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Cook-Deegan

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Nature|March 28, 2009
The dangers of diagnostic monopoliesRobert Cook-Deegan, Subhashini Chandrasekharan, Misha Angrist
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 16, 2010
Impact of gene patents and licensing practices on access to genetic testing for Alzheimer diseaseKatie Skeehan, Christopher Heaney, Robert Cook-Deegan
Journal of Law and the Biosciences|November 24, 2015
The Mouse That Trolled: The Long and Tortuous History of a Gene Mutation Patent That Became an Expensive Impediment to Alzheimer's ResearchTania Bubela, Saurabh Vishnubhakat, Robert Cook-Deegan
Journal of Health Politics, Policy and Law|July 25, 2022
The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible ReformsAmeet Sarpatwari, Aaron S Kesselheim, Robert Cook-Deegan
Genomics|March 16, 2010
Metastasizing patent claims on BRCA1Thomas B Kepler, Colin Crossman, Robert Cook-Deegan
Genome Medicine|April 4, 2009
Direct-to-consumer genetic tests: beyond medical regulation?David Magnus, Mildred K Cho, Robert Cook-Deegan
Science (New York, N.Y.)|October 7, 2006
Public health. Genomics and medicine at a crossroads in ChernobylGeoffrey S Ginsburg, Misha Angrist, Robert Cook-Deegan
Science Translational Medicine|July 5, 2013
AMP v. Myriad: a surgical strike on Blockbuster business modelsRichard E Gold, Robert Cook-Deegan, Tania Bubela
JAMA|February 24, 2022
Updating the Bayh-Dole Act: March-in Rights and TransparencyRobert Cook-Deegan, Aaron S Kesselheim, Ameet Sarpatwari
Genome Medicine|January 17, 2015
Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?Jae Yeon Cheon, Jessica Mozersky, Robert Cook-Deegan
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Nature|March 28, 2009
The dangers of diagnostic monopoliesRobert Cook-Deegan, Subhashini Chandrasekharan, Misha Angrist
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 16, 2010
Impact of gene patents and licensing practices on access to genetic testing for Alzheimer diseaseKatie Skeehan, Christopher Heaney, Robert Cook-Deegan
Journal of Law and the Biosciences|November 24, 2015
The Mouse That Trolled: The Long and Tortuous History of a Gene Mutation Patent That Became an Expensive Impediment to Alzheimer's ResearchTania Bubela, Saurabh Vishnubhakat, Robert Cook-Deegan
Journal of Health Politics, Policy and Law|July 25, 2022
The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible ReformsAmeet Sarpatwari, Aaron S Kesselheim, Robert Cook-Deegan
Genomics|March 16, 2010
Metastasizing patent claims on BRCA1Thomas B Kepler, Colin Crossman, Robert Cook-Deegan
Genome Medicine|April 4, 2009
Direct-to-consumer genetic tests: beyond medical regulation?David Magnus, Mildred K Cho, Robert Cook-Deegan
Science (New York, N.Y.)|October 7, 2006
Public health. Genomics and medicine at a crossroads in ChernobylGeoffrey S Ginsburg, Misha Angrist, Robert Cook-Deegan
Science Translational Medicine|July 5, 2013
AMP v. Myriad: a surgical strike on Blockbuster business modelsRichard E Gold, Robert Cook-Deegan, Tania Bubela
JAMA|February 24, 2022
Updating the Bayh-Dole Act: March-in Rights and TransparencyRobert Cook-Deegan, Aaron S Kesselheim, Ameet Sarpatwari
Genome Medicine|January 17, 2015
Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?Jae Yeon Cheon, Jessica Mozersky, Robert Cook-Deegan
Pageof 12